Empowering dialysis users and caregivers
Search for dialysis centres here
Log in to explore the world's most comprehensive database of dialysis centres for free!
Professional dialysis recruitment| Shares of Fresenius Medical Care Corporation (NYSE:FMS) Drops by -7.61% - American Trade Journal |
 |
 |
|
Fresenius Medical Care Corporation (NYSE:FMS) has lost 7.61% during the past week and dropped 12.15% in the last 4 weeks. The shares are however, negative as compared to the S&P 500 for the past week with a loss of 1.95%. Fresenius Medical Care Corporation (NYSE:FMS) has underperformed the index by 7.31% in the last 4 weeks. Investors should watch out for further signals and trade with caution. For the current week, the company shares have a recommendation consensus of Buy. Fresenius Medical Care Corporation (NYSE:FMS) witnessed a decline in the market cap on Friday as its shares dropped 3.75% or 1.48 points. After the session commenced at $39.13, the stock reached the higher end at $39.32 while it hit a low of $38.02. With the volume soaring to 177,397 shares, the last trade was called at $38.02. The company has a 52-week high of $44.34. The company has a market cap of $23,739 million and there are 624,394,000 shares in outstanding. The 52-week low of the share price is $32.4. Fresenius Medical Care AG & Co. KGAA has dropped 12.03% during the last 3-month period . Year-to-Date the stock performance stands at 3.42%. The company shares have rallied 9.22% in the past 52 Weeks. On June 4, 2015 The shares registered one year high of $44.34 and one year low was seen on October 16, 2014 at $32.4. The 50-day moving average is $41.93 and the 200 day moving average is recorded at $41.58. S&P 500 has rallied 1.35% during the last 52-weeks. Fresenius Medical Care Corporation (NYSE:FMS): 5 analysts have set the short term price target of Fresenius Medical Care Corporation (NYSE:FMS) at $43.61. The standard deviation of short term price target has been estimated at $5.04, implying that the actual price may fluctuate by this value. The higher and the lower price estimates are $ 50 and $39 respectively. Fresenius Medical Care AG & Co KGaA is a Germany-based kidney dialysis company that operates in the fields of dialysis care and dialysis products for the treatment of end-stage renal disease (ESRD). Its dialysis business is vertically integrated and offers products and services for the entire dialysis value chain, providing dialysis treatment at dialysis clinics it owns or operates and supplying these clinics with a range of products. The Company offers two types of dialysis treatment: Hemodialysis (HD), where the machine controls the blood from the patient through a special filter, the dialyzer, and Peritoneal Dialysis (PD), where the patients peritoneum is used as a dialyzing membrane. Its dialysis product portfolio includes chronic hemodialysis, home dialysis, renal pharmaceuticals, acute therapy, liver support, therapeutic apheresis, therapy support and water technology, among others. In addition, the Company sells dialysis products to other dialysis service providers. |
